rs8192720
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_000762.6(CYP2A6):c.22C>T(p.Leu8Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0118 in 1,609,772 control chromosomes in the GnomAD database, including 2,390 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in Lovd as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.019 ( 244 hom., cov: 31)
Exomes 𝑓: 0.011 ( 2146 hom. )
Consequence
CYP2A6
NM_000762.6 synonymous
NM_000762.6 synonymous
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.53
Genes affected
CYP2A6 (HGNC:2610): (cytochrome P450 family 2 subfamily A member 6) This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 19-40850405-G-A is Benign according to our data. Variant chr19-40850405-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.53 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.177 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP2A6 | ENST00000301141.10 | c.22C>T | p.Leu8Leu | synonymous_variant | Exon 1 of 9 | 1 | NM_000762.6 | ENSP00000301141.4 | ||
CYP2A6 | ENST00000596719.5 | n.36C>T | non_coding_transcript_exon_variant | Exon 1 of 6 | 1 | |||||
CYP2A6 | ENST00000600495.1 | n.22C>T | non_coding_transcript_exon_variant | Exon 1 of 6 | 1 | ENSP00000472905.1 | ||||
ENSG00000268797 | ENST00000601627.1 | n.118-41586G>A | intron_variant | Intron 1 of 3 | 3 | ENSP00000469533.1 |
Frequencies
GnomAD3 genomes AF: 0.0188 AC: 2849AN: 151164Hom.: 244 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
2849
AN:
151164
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0227 AC: 5675AN: 250066 AF XY: 0.0210 show subpopulations
GnomAD2 exomes
AF:
AC:
5675
AN:
250066
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0111 AC: 16203AN: 1458496Hom.: 2146 Cov.: 34 AF XY: 0.0110 AC XY: 7958AN XY: 725560 show subpopulations
GnomAD4 exome
AF:
AC:
16203
AN:
1458496
Hom.:
Cov.:
34
AF XY:
AC XY:
7958
AN XY:
725560
Gnomad4 AFR exome
AF:
AC:
954
AN:
33420
Gnomad4 AMR exome
AF:
AC:
207
AN:
44646
Gnomad4 ASJ exome
AF:
AC:
593
AN:
26078
Gnomad4 EAS exome
AF:
AC:
8533
AN:
38396
Gnomad4 SAS exome
AF:
AC:
408
AN:
85972
Gnomad4 FIN exome
AF:
AC:
1726
AN:
53296
Gnomad4 NFE exome
AF:
AC:
2749
AN:
1110732
Gnomad4 Remaining exome
AF:
AC:
975
AN:
60200
Heterozygous variant carriers
0
664
1328
1993
2657
3321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0188 AC: 2848AN: 151276Hom.: 244 Cov.: 31 AF XY: 0.0206 AC XY: 1523AN XY: 73864 show subpopulations
GnomAD4 genome
AF:
AC:
2848
AN:
151276
Hom.:
Cov.:
31
AF XY:
AC XY:
1523
AN XY:
73864
Gnomad4 AFR
AF:
AC:
0.0271305
AN:
0.0271305
Gnomad4 AMR
AF:
AC:
0.00678703
AN:
0.00678703
Gnomad4 ASJ
AF:
AC:
0.0190862
AN:
0.0190862
Gnomad4 EAS
AF:
AC:
0.186971
AN:
0.186971
Gnomad4 SAS
AF:
AC:
0.00988641
AN:
0.00988641
Gnomad4 FIN
AF:
AC:
0.0307795
AN:
0.0307795
Gnomad4 NFE
AF:
AC:
0.00318293
AN:
0.00318293
Gnomad4 OTH
AF:
AC:
0.0191571
AN:
0.0191571
Heterozygous variant carriers
0
111
222
334
445
556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
303
AN:
3428
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at